T helper cells recognize exogenous antigens in association with class II histocompatibility antigens (Ia antigens) on the surface of an antigen-presenting cell (APC) 1 (reviewed in reference 1). The best-studied APC (mononuclear phagocytes, dendritic cells, Langerhans cells) are derived from bone marrow precursors. In mouse, the ability of a population of macrophages to present antigen correlates with the proportion of macrophages that expresses Ia (2) . Similar results have been noted with macrophage cell lines (3) . T helper cells, when activated, secrete a lymphokine(s) that recruits Ia-positive macrophages from the bone marrow in vivo (4) and induces Ianegative macrophages to express Ia in vitro (5-7). Thus, T cells can recruit additional functional APC to amplify the immune response. Two preliminary reports have suggested that human mononuclear phagocytic cells may be under similar control (8, 
9).
Recent data (10, 11) have suggested that cultured human vascular endothelial cells may substitute for bone marrow-derived APC, presenting antigen to immunized T cells in vitro in an Ia-restricted manner. In these experiments, contaminating bone marrow-derived APC, especially dendritic cells, could have accounted for the results. Furthermore, Ia antigens could not be demonstrated on cultured human umbilical vein endothelial cells by indirect immunofluorescence using a mouse monoclonal antibody (8, 12) . Recently (i3), we have shown that although primary isolates of human umbilical vein endothelial cells do not express Ia antigens under standard culture conditions, they may be induced to do so by treatment of the cultures with phytohemagglutinin (PHA). In this paper, we report that the induction of endothelial Ia can be mediated by activated T cells as shown by transfer of medium conditioned by activated T ceils, by co-cuhivation with allogeneic T cells, and by addition of y * Supported by grants HL27642, AI18060, CA34129, and Program Project PO1 HL22602 from the National Institutes of Health.
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interferon, an activated T cell product. Thus, this similarity of T cell regulation of Ia expression on endothelial cells and classic APC supports the hypothesis that vascular endothelium may indeed function to present antigen.
Materials and Methods
Cells. Human umbilical vein endothelial (HUVE) cells were harvested by collagenase treatment of two to six normal term umbilical cord segments and pooled in Medium 199 containing 20% (vol/vol) heat-inactivated fetal bovine serum supplemented with 125 U/ml penicillin, 125 #g/ml streptomycin, and 2 mM L-glutamine (M199-FBS; all components from M. A. Bioproducts, Walkersville, MD) as described elsewhere (14) . Replicate primary cultures were plated (day 0) in either Costar 96 flat-bottomed microtiter wells (0.32 cm2/well) or Costar 24 flat-bottomed wells (2.0 cm2/well, both from M. A. Bioproducts). The cultures were washed (day 1) to remove unattached blood and endothelial cells and re-fed with M199-FBS. Cultures normally reached visual confluence (~0.75 × 105 cells/era 2) by day 3.
Peripheral blood mononuclear cells were sterilely isolated from heparinized (5% vol/vol heparin, 1,000 USP U/ml; Elkins-Sinn, Inc., Cherry Hill, NJ) adult peripheral venous blood by density step gradient centrifugation (15) using lymphocyte separation medium (LSM; Litton Bionetics, Inc., Kensington, MD). T cells and T cell subsets were also sterilely purified from adult peripheral venous blood. To prepare T cells, blood was defibrinated with glass beads, depleted of red cells by 1 g sedimentation through 3% dextran in HEPES-buffered Hanks' balanced saline solution (HBSS) and the erythrocyte-poor fractions were further purified by density step gradient centrifugation as above. The mononuclear cells from the interface were incubated on plastic for 1 h to remove adherent cells, washed, and then incubated with neuraminidase-treated sheep erythrocytes (Flow Laboratories, Inc., McLean, VA) for 15 min at 37°C in suspension and 1 h at 4°C as a pellet to form rosettes. Rosettes were collected by sedimentation through ice-cold LSM and washed in HEPES-buffered HBSS with 5% FBS; the sheep erythrocytes were lysed with buffered ammonium chloride. Finally, the T cells were further depleted of adherent cells by an additional overnight incubation on plastic. This population stained >95% positive with mouse monoclonal antibody Leu-1 (Becton, Dickinson & Co., Sunnyvale, CA). T cell subsets (i6) were prepared by cell sorting of cells stained by indirect immunofluorescence using mouse monoclonal antibody OKT4 (Ortho Diagnostic Systems Inc., Westwood, MA) diluted 1:100 in HBSS with 4% wt/vol bovine serum albumin and fluorescein-conjugated rabbit anti-mouse immunoglobulin, F(ab')2 fragment at 0.5 mg/ml in the same buffer. Staining and sorting were performed at ice temperature using a FACS II cell sorter (B-D FACS Systems, Becton, Dickinson & Co.). The purity of the sorted cells was assessed by reanalyzing the sorted population using the same criteria used for sorting.
Treatment of Primary HUVE Cultures. HUVE cell cultures were treated by addition of 4/*g/ ml PHA (type IV leucoagglutinin; Sigma Chemical Co., St. Louis, MO) or conditioned medium in M199-FBS on either day 1 (subconfluent) or on day 4 (at confluence). Medium conditioned by activated peripheral blood mononuclear cells was produced by incubating peripheral blood mononuclear cells in M199-FBS containing 4 #g/ml PHA at 2 X 10 ~ cells/ml for 24 h at 37°C in a humidifed 5% CO2 environment. This medium was used undiluted in place of fresh M 199-FBS. Media conditioned by clones derived from the Jurkat T cell line were gifts of Dr. Jack Strominger (Sidney Farber Cancer Institute, Boston, MA) and Dr. Terry Strom (Brigham and Women's Hospital, Boston, MA). These were used at concentrations from 0.1 to 10% (vol/vol) in M199-FBS and were compared with matched control media not incubated with cells. Finally, media containing human ?, interferon were produced by a cloned Chinese hamster ovary cell line transfected wilh a plasmid containing the human y interferon gene (17) . Characterization of the cloned cell line is to be described in detail elsewhere. This cell line constitutively secretes human y interferon. Matching medium from a cloned Chinese hamster ovary cell line not containing the y interferon gene was used as a control. These conditioned media were added at concentrations of 0.2-10% (vol/vol) in M 199-FBS. None of the mitogens or conditioned media showed any cytopathic effect upon the HUVE cells at the concentrations used in these experhnents.
Co (13) . Immunocytochemistry at the electron microscope level (22) was performed using HUVE cultures or co-cultures of HUVE cells and blood cells in Costar 24 wells. In brief, cells were stained as for radioimmunoassay with saturating amounts of mouse monoclonal antibodies in 500/xl and detecting antibody in 250 /11 of 1% (wt/vol) bovine serum albumin (Sigma Chemical Co.) in HBSS (with calcium; M. A. Bioproducts); the detecting antibody was rabbit anti-mouse immunoglobulin coupled to horseradish peroxidase. After the final wash, the cell monolayer was lightly fixed with 1.25% glutaraldehyde in 0.1 M sodium eacodylate, pH 7.4, for 2 h at 4°C and then washed three times with 0.05 M Tris-HCl, pH 7.56 (Tris buffer). The cells were incubated with diaminobenzidine and hydrogen peroxide (5 mg diaminobenzidine, 0.1 ml of 1% H202/10 ml Tris buffer) for 40 rain at room temperature, and excess substrate was removed by three washes with Tris buffer. Each well was post-fixed with 2% aqueous osmium tetroxide for 30 min at room temperature and then dehydrated and embedded in Epon, and the monolayer was reembedded at right angles to the original plane of the culture dish to obtain cross-sections. These sections were examined by electron microscopy using a Philips 201 electron microscope (Philips Electronic Instruments, Inc., Mahwah, N J).
Immunofluorescence flow cytometry was performed using HUVE cultures or co-cultures of HUVE cells plus blood cells in Costar 24 wells. Cells were suspended by two washes with calcium-free HBSS followed by incubation with trypsin-versene mixture (M. A. Bioproducts) for 5 min at 37~C. After gentle tituration with a pasteur pipette, the trypsin was quenched by addition of M 199-FBS. This protocol yields a nearly monodisperse suspension (a few lymphocyte-endothelial couplets persist) of trypan blue dye-excluding cells and does not alter staining for Ia antigens. The suspension was washed twice with bovine serum albumin-Dulbecco's phosphate-buffered saline using the clinical centrifuge and labeled as for the radioimmunoassay with saturating amounts of monoclonal antibodies and detecting antibody (fluorescein isothiocyanate [FITC]-rabbit anti-mouse immunoglobulin). The final washed cell pellets were fixed by suspension in freshly made 1% paraformaldehyde (Fisher Scientific Co., Pittsburgh, PA). PHA-treated cultures, the entire population has become HLA-DR-positive (Fig. 1 B) . An incidental but reproducible finding is that Ia-positive endothelial cells appear slightly smaller as judged by electronic volume than Ia-negative cells. This change probably correlates with the change in cell shape noted previously (13) . Several human Ia antigens in addition to HLA-DR have been recently described. The mouse monoclonal antibody I-LR1 is a polymorphic reagent that recognizes a subset of allelic products of the SB locus (20) . Endothelial cells in untreated cultures derived from several pooled donors appear SB-negative (i.e., do not bind I-LR 1, Fig.  1 C) and upon PHA treatment, ~40% of the endothelial cells bind I-LR1 (Fig. 1 D) , whereas ~60% of the cells remain indistinguishable from the untreated control. This result has two implications. First, it shows that more than one Ia antigen (DR and SB) are coordinately induced. Similar results by radioimmunoassay have been obtained for mouse monoclonal antibodies Genox 3.53 and I-LR2 polymorphic reagents that recognize products of other human Ia loci (not shown). Second, the fact that ~40% of the cells in these pooled cultures become discretely I-LR 1 binding, whereas -60% remain nonbinding (a bimodal distribution), suggests that each endothelial cell synthesizes its own Ia. According to this interpretation, every cell has become SB antigen-positive, but only 40% of the cells genetically encode for SB antigens recognized by I-LRI. If, on the other hand, Ia were being shed into the medium and passively bound by endothelium, it would be expected that every cell should have T CELLS INDUCE VASCULAR ENDOTttELIAL Ia become I-LR1 reactive to some degree, as was seen with the monomorphic anti-HLA-DR antibody LB3.1 (Fig. 1, A and C) .
The Induction of Endothelial Ia by PHA Is Mediated by T Cells. PHA could act directly upon endothelial cells to induce Ia expression or could activate a minor cell population in the culture, which in turn would act upon endothelial cells or could do both. The most likely candidate for a mediator cell is the T lymphocyte. T cells were not detectable in the primary HUVE cultures by morphology or by monoclonal antibody binding assays with the anti-human T cell mouse monoclonal antibodies OKT3 or Leu-1. Furthermore, the cultures were multiply washed, a condition not expected to retain T cells, a nonadherent (to plastic) cell type. Nevertheless, T cells could be involved because (a) T cells, although nonadherent to plastic, bind tenaciously to cultured vascular endothelium (23, and personal observations); (b) in general, very few T cells can produce enough lymphokine to affect many target cells; and (c) both PHA and concanavalin A (Con A), another potyclonal T cell activator, induce endothelial Ia expression at doses that activate T cells.
Direct evidence for the role of T cells in mediating endothelial Ia expression was obtained by the following experiment. Primary HUVE cultures were treated either with complement alone (mock-treated) or with anti-human T cell mouse monoclonal antibody OKT3 plus complement before the addition of PHA. Endothelial cells in cultures treated with OKT3 plus complement no longer express Ia in response to PHA, whereas mock-treated cultures respond as usual (Fig. 2) . Similar results were obtained with Con A (data not shown). In other experiments, use of mouse myeloma Replicate HUVE primary cultures were plated oil day 0, treated with OKT3 plus complement or complement alone on day l, and immediately treated with fresh MI99-FBS (untreated), M199-FBS containing 4/*g/ml Pt tA, M 199-FBS conditioned for 24 h by 2 X 1() ~ peripheral blood mononuclear cells/ml in 4 ,ag/ml PHA (PHA-PBL CM), and MI99-FBS containing 1% Chinese hamster ovary cell conditioned medium by cells expressing human y interferon (T-IFN medium containing 5 X 10 4 U/ml assayed on FS4 cells) and not expressing human y interferon (control medium). Cultures were assayed for Ia expression by double antibody radioimmunoassay on day 4.
proteins or mouse monoclonal antibodies not reactive with human T cells of the same immunoglobulin class as OKT3 plus complement also had no effect upon the PHA response (data not shown). There was no evidence of a cytopathic effect upon the endothelial cells after treatment with OKT3 plus complement. Most importantly, medium conditioned by human peripheral blood mononuclear cells treated with the same dose of PHA was effective in inducing endothelial cell [a expression even after treatment with OKT3 plus complement (Fig. 2) . The efficacy of different samples of conditioned medium was variable, which suggests that a labile factor was involved. The role of a T cell factor in the induction of endothelial Ia was further suggested by the following two types of experiments. (Fig. 4) . By immunocytochemistry, we have confirmed that the Ia-positive large cells are morphologically identifiable endothelial cells (Fig. 5) . By fluorescence flow cytometry and immunocytochemistry, most of the small cells remain Ia-negative. These results have four implications. First, incubation with allogeneic peripheral blood mononuclear cells induces Ia in the absence of lectin. The exogenous T cells appear to be the important effectors because OKT3 plus complement pretreatment of the HUVE cultures has no effect upon Ia induction (data not shown). Second, endothelial Ia expression precedes T cell proliferation, which suggests that T cell activation but not proliferation is needed for Ia induction. In fact, y irradiation (1,200 rad) of the blood cells to prevent proliferation does not alter the induction of endothelial Ia (data not shown). Third, the presence of discretely Ia-negative and positive endothelial cells in the culture at 24 and 48 h again suggests that endothelial cells synthesize Ia rather than absorb Ia shed by other cells into the medium. Finally, Ia appears sufficiently early in the co-culture that it could be a major stimulator of allogeneic T cell proliferation in the response to endothelium, as has been shown in the mixed lymphocyte reaction (reviewed in reference 25).
Co-Culture with Allogeneic T Cells Induces Endothelial Ia in the
The peripheral blood mononuclear cells added to HUVE cells in the previous experiment are predominantly T cells, but contain several other cell types. To better establish a role for T cells in this phenomenon, we further fractionated the blood mononuclear cells. Fractions enriched for T cells by E-rosette formation retained Iainducing activity (data not shown). After overnight adherence to plastic, the T cellenriched population was further separated into the OKT4-positive (>96% OKT4-FIc~. 5. Immunocytocbemical localization of mouse monoclonal (A) anti-human la (LB3.I) and (B) anti-human T cell (Leu-1) antibodies to cells in co-culture of human endothelium with peripheral blood mononuclear cells after 72 h. Most of the morphologically identified endothelial cells (lower ceils in both panels) were la-positive, whereas most of the T ceils (upper ceils in both panels) were Ia-negative. This result confirms that the Ia-positive large cells analyzed by flow cytometry (Fig. 4) positive) and OKT4-negative (<2% OKT4-positive) subsets by means of the fluorescence-activated cell sorter. Both of these cell populations still proliferated in response to PHA or to an allogeneic B cell lymphoblastoid line, which suggests that some residual APC remained. Whereas whole peripheral blood mononuclear cells fail to induce endothelial Ia below a 10:1 ratio (1.5 X 106 mononuclear cells per 1.5 X 105 HUVE cells in a flat-bottomed Costar 24 well, surface area 2.0 cm2), both the OKT4 + and OKT4-subsets were effective endothelial Ia inducers at 1.0 X 106 cells/well and the OKT4 + subset was still active at 3.0 × 105 cells (Table I) . Thus, T cell-enriched fractions are more potent endothelial Ia inducers than total peripheral blood mononuclear cells and monocyte-enriched fractions do not have discernible Ia-inducing activity. These data suggest the activity resides in the T cell population.
T Interferon Induces Endothelial Cell Ia Expression.
As shown earlier, conditioned medium from PHA-activated peripheral blood mononuclear cells induced endothelial cell Ia expression in primary HUVE cultures treated with OKT3 plus complement.
To establish that T cells were the source of the factor(s), we have examined several preparations of known human lymphokines. Conditioned medium from some clones of the Jurkat T cell line, a known producer of lymphokines (26), were effective Ia inducers, whereas medium conditioned by other clones did not work; this activity did not correlate with measurable interleukin 2 (data not shown). Recently, the gene for human Y interferon has been cloned in a plasmid (17) and introduced into a Chinese hamster ovary cell line, and clones have been isolated that constitutively secrete y interferon into the medium. We compared the activity of y interferon-containing conditioned medium with that of conditioned medium from a matching Chinese hamster ovary cloned cell line not containing the 3' interferon gene. Whereas the control conditioned medium had no Ia-inducing activity, the T interferon preparations have extremely potent endothelial cell Ia-inducing activity (Figs. 2 and  6 ). Thus, y interferon, a protein produced by activated T cells, induces endothelial Ia.
Discussion
Recent studies (10, 11) have suggested that human vascular endothelial cells in culture can act as immune accessory cells, presenting antigen to immunized T cells in an Ia-restricted manner. Since contaminating bone marrow-derived APC could be present, a demonstration that the endothelial cells in these cultures were, in fact, Iapositive is necessary to support the interpretation that endothelial cells can function as APC.
HLA-DR typing sera and rabbit anti-human Ia xenosera have been shown to be cytotoxic for cultured HUVE cells (27) (28) (29) . However, these sera may cross-react with alloantigens other than Ia (e.g., endothelial-monocyte alloantigens not expressed on lymphocytes). More recent reports (8, 12) using binding of mouse monoclonal antibodies reactive with human Ia analyzed by fluorescence flow cytometry have reported that human endothelial cells in culture are Ia-negative. Our earlier results (13) demonstrated that HUVE cells do not bear Ia under standard culture conditions, but that Ia could be induced in culture. Here we extend these observations to show that every HUVE cell synthesizes and expresses Ia and that T cells, activated by lectin or alloantigen, mediate the induction of endothelial Ia. T cells appear to work, at least in part, by release of soluble mediators (i.e., conditioned medium induces Ia) and that y interferon, a protein secreted by activated T cells, acts directly to induce endothelial Ia. Therefore, experiments that have used HUVE cell cultures to support antigen-or lectin-dependent T cell proliferation (10, 11, 30) may have started with Ia-negative endothelial cell populations, but our results predict that once T cell activation has begun, perhaps with residual contaminating monocytes in the T cell population acting as APC, the activated T cells will induce endothelial Ia expression, recruiting additional APC in vitro.
There are two previous reports that suggest that some endothelial cell functions may be under lymphocyte control. First, medium conditioned by the human lymphoblastoid cell line RPMI 8392 or by activated (by lectin or antigen) peripheral blood mononuclear cells inhibit the migration of bovine endothelial cells in culture (31) . Second, supernatants from mixed lymphocyte cultures appear mitogenic for bovine endothelial cells (32) . Human leukocyte (c~) interferon has also been shown to inhibit the migration of bovine endothelial cells (33) , hut immune (Y) interferon has not been tested.
Endothelial Ia arises early in the course of co-culture with T cells; about one-third of the cells are Ia-positive by 24 h. For this reason, we have suggested that endothelial Ia could be a major stimulator of the subsequent T cell proliferation, just as it is in the response to allogeneic blood mononuclear cells (25) . This hypothesis needs to be tested. What activates exogenous allogeneic T cells before Ia is induced? It is possible that a small number of Ia-positive cells are present in the primary HUVE cultures, either a subpopulation of endothelium or, more likely, a contaminating population of bone marrow-derived APC (monocytes, tissue macrophages, or dendritic cells). Although these cells are few, they could trigger an occasional responding T cell to release an endothelial cell Ia-inducing factor, perhaps y interferon. Alternatively, the exogenous T cells have been added with their own APC, even in the case of our enriched T cell subsets, and these APC can function to present foreign HLA-A,B antigens that are clearly expressed in untreated cultures. Presentation of alloantigens by syngeneic APC has been seen in the murine mixed lymphocyte reaction (34) .
The induction of endothelial Ia by activated T cells has a striking parallel in the induction of murine macrophage Ia by activated T cells. The factor(s) responsible for macrophage Ia induction may be y interferon, but the identity of the Ia-inducing factor has not been established. Preparation of partially purified murine y interferon increases the percentage of Ia-positive thymocytes, but the authors of this report could not distinguish between induction of Ia or selection for Ia-positive cells (35) . Human monocyte Ia may be regulated (8, 9) , but these cells are uniformly Ia-positive upon isolation and Ia quantitatively increases in culture without additional perturbations (36) . Therefore, induction of Ia in human monocytes has been difficult to study. The human endothelial cell system thus has two clear experimental advantages: (a) human y interferon, through the techniques of molecular genetics, is available free of all other contaminating human proteins, whereas mouse 3' interferon of similar purity is not yet available; and (b) untreated endothelial cells in culture are uniformly Ia-negative and may be uniformly induced to express Ia. The present report offers evidence that y interferon does induce endothelial cell Ia and thus accounts for at least some of the Ia-inducing activity of medium conditioned by activated lymphocytes or T cell lines. These results differ from those recently reported using cloned human y interferon to treat a B lymphoblastoid cell line; HLA-A,B antigens were increased but Ia antigens were not affected (37) .
A biological role for endothelial Ia expression in vivo is not clear. Endothelial cells could have the specific task of presenting Ia plus foreign antigen to the circulation, serving to recruit antigen-specific T helper cells into the site of an immune response. Ia expression would be induced when needed. The consequences of inducible Ia on vascular endothelium may extend to allograft rejection. Ia-bearing cells are markedly more immunogenic than Ia-negative cells (38) , and this observation has led to the theory of Ia-positive passenger leukocytes as being important determinants of the rejection of kidney and other organ grafts (39) . Our data suggest that it may be important to suppress endothelial Ia expression in conjunction with depletion of passenger leukocytes in order to improve graft survival. 
